Company NewsPresentations Scientific Poster from ATS: Respiratory Innovation Summit 2022 May 13-14th Dr. Rahmo attended the American Thoracic Society: Respiratory Innovation Summit in San Francisco,…adminMay 16, 2022
Company NewsPresentations ATS: Respiratory Innovation Summit 2022 May 13-14th Dr. Rahmo will be attending the American Thoracic Society: Respiratory Innovation Summit in San Francisco,…adminMay 12, 2022
Company NewsPresentations Medicinal Chemistry Strategy Meeting – 2022 Dr. Rahmo will have the pleasure of leading a roundtable at the Medicinal Chemistry Strategy…adminMay 4, 2022
Company NewsPresentations Health 2.0 – Presentation Dr. Rahmo attended the Health 2.0 Conference in Las Vegas, where he was asked to…adminApril 13, 2022
Company NewsPresentations Health 2.0 Conference 2022 Dr. Abdulkader Rahmo is proud to be speaking about 'Stem Cell Treatment For Lung Disease'…adminMarch 22, 2022
Company NewsPresentations Advanced Therapies Week: Phacilitate 2022 Dr. Abdulkader Rahmo introduced Small Mobile Stem (SMS) cells to the market at Phacilitate’s Advanced Therapies…adminJanuary 29, 2022
Company News SMSbiotech Welcome Beth Thompson-Webb to Board of Directors SMSbiotech would like to announce that Beth Thompson-Webb has joined the Board of Directors in…adminJanuary 25, 2022
Company NewsPresentations 5th Meridian Clinical Trials Event We are glad to announce that Continuum Globe Ltd has onboarded Dr. Abdulkader Rahmo as a speaker…adminOctober 5, 2021
Company NewsCOPD SMSbiotech Successfully Completes First Test of a Series of Animal Studies for COPD Treatment SAN DIEGO, CA, September 17, 2021 - SMSbiotech is very excited to launch its new…adminSeptember 21, 2021
Company News SMSbiotech Announces Collaboration with Acculab Life Sciences SAN DIEGO, CA, September 1, 2021 —SMSbiotech, Inc. announced today their collaboration with Acculab Life…adminSeptember 1, 2021